News

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.
A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...
“I agree in this case with FDA that efficacy data are important to see ... to run a new clinical trial of its protein-based COVID-19 vaccine after the agency grants full approval, sowing ...
Prasad has long criticized the FDA for granting emergency use authorization for COVID-19 vaccine boosters ... changes could result in changes to efficacy and safety. "Without trials, it is ...
Vaccines for new diseases are often tested against a placebo, like saline or another inert substance, to test their safety ...
It is also planning to develop other vaccines for COVID-19 using BPL, which it calls "traditional ... and subjected to the highest standards of safety and efficacy testing," Kennedy said.